Registry for patients with ATTR amyloidosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to create a comprehensive registry of patients diagnosed with ATTR amyloidosis, collecting data at diagnosis and throughout follow-up. The goal is to describe the natural history of the disease in a real-world context and to develop and validate prognostic models and response criteria that can be applied at any stage of the condition. The registry will facilitate collaboration among amyloidosis experts and provide diagnostic resources to physicians across Italy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Suspected diagnosis of systemic and localized amyloidosis;
2. age .18 years;
3. ability to understand and willingness to sign an informed consent (patients who already sign informed consent for clinical data to be used in retrospective analyses will be accepted);
4. planned (or ongoing) follow-up at participating center.

Exclusion Criteria:

1\. Diagnosis of light chain (AL) amyloidosis

Where it's running

• Fondazione IRCCS Policlinico San Matteo
  Pavia, Italy Recruiting
• ASST Ovest Milanese - Ospedale di Legnano
  Legnano, Mi, Italy Not yet recruiting
• AOU San Luigi Gonzaga
  Orbassano, To, Italy Not yet recruiting
• AOU Ospedali Riuniti
  Ancona, Italy Not yet recruiting
• Policlinico di Bari
  Bari, Italy Not yet recruiting
• ASST Papa Giovanni XXIII
  Bergamo, Italy Not yet recruiting

Study contacts

• Study coordinator: Paolo Milani, MD, PhD
• Email: p.milani@smatteo.pv.it
• Phone: +390382502994

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Hungarian National Systemic Amyloidosis Registry

  This registry collects medical data from adults with systemic amyloidosis across Hungary to help understand how the disease is diagnosed and treated in real-world practice.

  Recruiting at 12 sites Semmelweis University · Balatonfüred and 11 other locations · NCT07689331

• Understanding the characteristics and treatment of patients with ATTR amyloidosis

  This study is looking to understand the experiences and treatments of people with ATTR amyloidosis to see how the disease affects their lives and how it is managed over time.

  Recruiting at 5 sites AstraZeneca · Eden Prairie, Minnesota and 28 other locations · NCT06355934

• Observational study of patients with ATTR amyloidosis

  This study looks at the characteristics of people with ATTR amyloidosis and tests how well existing treatments work for them in real life.

  Recruiting at 38 sites Alnylam Pharmaceuticals · La Jolla, California and 39 other locations · NCT04561518

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.